Purpose. Growing evidence suggests different systemic exposure of anti-vascular endothelial growth factor (anti-VEGF) agents with repeated intravitreal application. Since the penetration of anti-VEGF agents through vascular barrier was reported, the interaction of anti-VEGF with nonresident platelets has become a topic of interest. The purpose of this study was to evaluate, with the help of visualization techniques, whether platelets take up the anti-VEGF agents ranibizumab, aflibercept, and bevacizumab. Methods. The uptake of anti-VEGF agents with or without VEGF treatment was investigated using immunofluorescence and immunogold staining in human platelets. The role of actin filaments and clathrin-coated vesicles in the transport of ranibi...
Pathologic arterial thrombosis is the leading cause of death in many countries. Current therapies pr...
Purpose Inhibition of vascular endothelial growth factor (VEGF) is a promising strategy to treat ret...
Abstract Background The ability to image vascular endothelial growth factor (VEGF) could enable pros...
This study was conducted to compare the effects of two anti-VEGF-A drugs, Ranibizumab and Aflibercep...
AbstractMembers of the vascular endothelial growth factor (VEGF) family differently regulate process...
Introduction: At the clinical introduction of antiangiogenic agents as anticancer agents, no major t...
The immunoreactive bands for mouse VEGF-A were observed in the aflibercept-probed blot, but not in t...
Anti-vascular endothelial growth factors (anti-VEGF) are targeted biological drugs (e.g. monoclonal ...
Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other ant...
BACKGROUND: The ability to image vascular endothelial growth factor (VEGF) could enable prospective,...
AbstractBevacizumab is one of the VEGF-binding proteins that are established in clinical practice to...
Platelets play an important role in thrombosis and in neo-vascularisation as they release and produc...
Abciximab is a new antiplatelet therapeutic in ischemic cardiovascular disease. The drug, chimeric F...
PurposeTo assess the interaction between ranibizumab, aflibercept, and mouse vascular endothelial gr...
The objectives of this study were to evaluate the relative binding and potencies of three inhibitors...
Pathologic arterial thrombosis is the leading cause of death in many countries. Current therapies pr...
Purpose Inhibition of vascular endothelial growth factor (VEGF) is a promising strategy to treat ret...
Abstract Background The ability to image vascular endothelial growth factor (VEGF) could enable pros...
This study was conducted to compare the effects of two anti-VEGF-A drugs, Ranibizumab and Aflibercep...
AbstractMembers of the vascular endothelial growth factor (VEGF) family differently regulate process...
Introduction: At the clinical introduction of antiangiogenic agents as anticancer agents, no major t...
The immunoreactive bands for mouse VEGF-A were observed in the aflibercept-probed blot, but not in t...
Anti-vascular endothelial growth factors (anti-VEGF) are targeted biological drugs (e.g. monoclonal ...
Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other ant...
BACKGROUND: The ability to image vascular endothelial growth factor (VEGF) could enable prospective,...
AbstractBevacizumab is one of the VEGF-binding proteins that are established in clinical practice to...
Platelets play an important role in thrombosis and in neo-vascularisation as they release and produc...
Abciximab is a new antiplatelet therapeutic in ischemic cardiovascular disease. The drug, chimeric F...
PurposeTo assess the interaction between ranibizumab, aflibercept, and mouse vascular endothelial gr...
The objectives of this study were to evaluate the relative binding and potencies of three inhibitors...
Pathologic arterial thrombosis is the leading cause of death in many countries. Current therapies pr...
Purpose Inhibition of vascular endothelial growth factor (VEGF) is a promising strategy to treat ret...
Abstract Background The ability to image vascular endothelial growth factor (VEGF) could enable pros...